Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Janux Therapeutics, Inc. | 7,722 | reported | 30 Sept 2024 | tx 51+4,770−1,005,822 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 1,826 | 46.19 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 8,894 | 46.42 USD | |
| 30 Sept 2024 | SALE | Janux Therapeutics, Inc. | 958 | 46.24 USD | |
| 30 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 123 | 39.80 USD | |
| 30 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 181 | 13.22 USD | |
| 30 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 181 | 10.73 USD | |
| 30 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 434 | 17.00 USD | |
| 26 Sept 2024 | SALE | Janux Therapeutics, Inc. | 49,497 | 46.78 USD | |
| 26 Sept 2024 | SALE | Janux Therapeutics, Inc. | 9,592 | 46.78 USD | |
| 26 Sept 2024 | SALE | Janux Therapeutics, Inc. | 50,539 | 46.78 USD | |
| 26 Sept 2024 | SALE | Janux Therapeutics, Inc. | 40,803 | 47.77 USD | |
| 26 Sept 2024 | SALE | Janux Therapeutics, Inc. | 7,908 | 47.77 USD | |
| 26 Sept 2024 | SALE | Janux Therapeutics, Inc. | 41,661 | 47.77 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 45,894 | 46.42 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 46,861 | 46.42 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 1,511 | 47.74 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 293 | 47.74 USD | |
| 27 Sept 2024 | SALE | Janux Therapeutics, Inc. | 1,542 | 47.74 USD | |
| 27 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 828 | 17.00 USD | |
| 27 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 345 | 10.73 USD | |
| 27 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 345 | 13.22 USD | |
| 27 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 234 | 39.80 USD | |
| 30 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 123 | 0.00 USD | deriv |
| 30 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 181 | 0.00 USD | deriv |
| 30 Sept 2024 | EXERCISE | Janux Therapeutics, Inc. | 181 | 0.00 USD | deriv |